The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
STAT3 is a potential modulator of HIF‐1‐mediated VEGF expression in human renal carcinoma cells
Abstract
Aberrantly enhanced vascular endothelial growth factor (VEGF) gene expression is associated with increased tumor growth and metastatic spread of solid malignancies, including human renal carcinomas. Persistent activation of STAT3 is linked to tumor‐associated angiogenesis, but underlying mechanisms remain unclear. Therefore, we examined whether STAT3 modulates the stability and activity of hypoxia‐inducible factor‐1α (HIF‐1α), and in turn enhances VEGF expression. We found that STAT3 was activated in ischemic rat kidneys and hypoxic human renal carcinoma cells. We also found that hypoxia‐induced activation of STAT3 transactivated the VEGF promoter and increased the expression of VEGF transcripts. Consistent with these findings, STAT3 inhibition attenuated the hypoxic induction of VEGF. Interestingly, activated STAT3 increased HIF‐1α protein levels due to the HIF‐1α stability by blocking HIF‐1α degradation and accelerated its de novo synthesis. The novel interaction of STAT3 with HIF‐1α was identified in hypoxic renal carcinoma cells. Furthermore, hypoxia recruited STAT3, HIF‐1α, and p300 to the VEGF promoter and induced histone H3 acetylation. Therefore, these findings provide compelling evidence that a causal relationship exists between STAT3 activation and HIF‐1‐dependent angiogenesis and suggest that therapeutic modalities designed to disrupt STAT3 signaling hold considerable promise for the blocking tumor growth and enhancing apoptosis of cancer cells and tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743
Ohh, M., Park, C. W., Ivan, M., Hoffman, M. A., Kim, T.-Y., Huang, L. E., Pavletich, N., Chau, V., & Kaelin, W. G. (2000) · Nature Cell Biology · doi:10.1038/35017054 · Cited by 1,577
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Huang, L. E., Arany, Z., Livingston, D. M., & Bunn, H. F. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.32253 · Cited by 1,190
Oxygen sensing and molecular adaptation to hypoxia
Bunn, H. F., & Poyton, R. O. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.3.839 · Cited by 1,172
Wenger, R. H. (2002) · The FASEB Journal · doi:10.1096/fj.01-0944rev · Cited by 1,135
HIF-1 and tumor progression: pathophysiology and therapeutics
Semenza, G. L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02317-1 · Cited by 1,060
An essential role for p300/CBP in the cellular response to hypoxia
Arany, Z., Huang, L. E., Eckner, R., Bhattacharya, S., Jiang, C., Goldberg, M. A., Bunn, H. F., & Livingston, D. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.12969 · Cited by 790
Regulation of the Hypoxia-inducible Transcription Factor 1α by the Ubiquitin-Proteasome Pathway
Kallio, P. J., Wilson, W. J., O'Brien, S., Makino, Y., & Poellinger, L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6519 · Cited by 754
Kallio, P. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6573 · Cited by 666
Ema, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1905 · Cited by 587
STAT proteins and transcriptional responses to extracellular signals
Horvath, C. M. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01624-8 · Cited by 482
Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H., & Poellinger, L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.402-415.2000 · Cited by 385
STAT signaling in head and neck cancer
Song, J. I., & Grandis, J. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203483 · Cited by 374
Transcriptional Response to Hypoxia in Human Tumors
Lal, A., Peters, H., St. Croix, B., Haroon, Z. A., Dewhirst, M. W., Strausberg, R. L., Kaanders, J. H. A. M., van der Kogel, A. J., & Riggins, G. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.17.1337 · Cited by 320
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Ebert, B. L., & Bunn, H. F. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.4089 · Cited by 282
The role of STATs in myeloid differentiation and leukemia
Coffer, P. J., Koenderman, L., & de Groot, R. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203479 · Cited by 226
STAT signaling in the pathogenesis and treatment of leukemias
Lin, T. S., Mahajan, S., & Frank, D. A. (2000) · Oncogene · doi:10.1038/sj.onc.1203486 · Cited by 205
Harmey, J. H., Dimitriadis, E., Kay, E., Redmond, H. P., & Bouchier-Hayes, D. (1998) · Annals of Surgical Oncology · doi:10.1007/bf02303785 · Cited by 192
Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma Cells
Huang, M., Page, C., Reynolds, R. K., & Lin, J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5931 · Cited by 189
STAT proteins as novel targets for cancer therapy
Catlett-Falcone, R., Dalton, W. S., & Jove, R. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00010 · Cited by 184
The IL-7 Receptor Controls the Accessibility of the TCRγ Locus by Stat5 and Histone Acetylation
Ye, S.-K., Agata, Y., Lee, H.-C., Kurooka, H., Kitamura, T., Shimizu, A., Honjo, T., & Ikuta, K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00230-8 · Cited by 182
Self-citationSchaefer, L. K., Ren, Z., Fuller, G. N., & Schaefer, T. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205263 · Cited by 170
Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
Desbaillets, I., Diserens, A., de Tribolet, N., Hamou, M., & Meir, E. G. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202424 · Cited by 112
Agani, F. H., & Semenza, G. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.5.749 · Cited by 103
Chun, Y., Choi, E., Kim, G., Lee, M. J., Lee, M.-J., Lee, S.-E., Kim, M., & Park, J.-W. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2180 · Cited by 61
Self-citationSle1ab Mediates the Aberrant Activation of STAT3 and Ras-ERK Signaling Pathways in B Lymphocytes
Liu, K., Liang, C., Liang, Z., Tus, K., & Wakeland, E. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1630 · Cited by 44
Cited by
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Yang, W., Yu, T., Huang, X., Bilotta, A. J., Xu, L., Lu, Y., Sun, J., Pan, F., Zhou, J., Zhang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18262-6 · Cited by 1,042
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 716
Aggarwal, B. B., Kunnumakkara, A. B., Harikumar, K. B., Gupta, S. R., Tharakan, S. T., Koca, C., Dey, S., & Sung, B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04911.x · Cited by 649
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Metadata
- Authors
- Jung, J. E., Lee, H., Cho, I., Chung, D. H., Yoon, S., Yang, Y. M., Lee, J. W., Choi, S., Park, J., Ye, S., & Chung, M.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-05-26
- Volume
- 19
- Issue
- 10
- Pages
- 1296-1298
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2123373938
- Cited by
- 425
- References
- 33
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.